PhaseV

1 stories about PhaseV
Raviv Pryluk PhaseV

PhaseV raises $15 million to optimize clinical trials with causal machine learning

24.10.23|CTech
The Israeli startup detects hidden signals in clinical data and extracts actionable insights for planning the next steps